Kymera Therapeutics COO Chadwick to Retire

Dow Jones
06/09

By Elias Schisgall

 

Kymera Therapeutics Chief Operating Officer Jeremy Chadwick is retiring.

Chadwick will remain with the company as an adviser through the end of the year, Kymera said Monday. The biotechnology company did not give an exact date for his retirement.

Kymera also appointed Penny Carlson to serve as senior vice president, developmental operations. Carlson previously served as head of global clinical development operations at Takeda.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

June 08, 2026 18:17 ET (22:17 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10